X. Jaïs, D. Armini, A. Jansa, P. Torbicki, A. Delcroix et al., Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension, Journal of the American College of Cardiology, vol.52, issue.25, pp.217-251, 2008.
DOI : 10.1016/j.jacc.2008.08.059

L. Rubin, M. Hoeper, W. Klepetko, N. Galié, I. Lang et al., Current and Future Management of Chronic Thromboembolic Pulmonary Hypertension: From Diagnosis to Treatment Responses, Proceedings of the American Thoracic Society, vol.3, issue.7, pp.601-608, 2006.
DOI : 10.1513/pats.200605-111LR

P. Guilpain, D. Montani, G. Damaj, L. Achouh, F. Lefrère et al., Pulmonary Hypertension Associated with Myeloproliferative Disorders: A Retrospective Study of Ten Cases, Respiration, vol.76, issue.3, pp.295-302, 2008.
DOI : 10.1159/000112822

URL : https://hal.archives-ouvertes.fr/hal-00356272

K. Hamaoka, M. Nakagawa, N. Furukawa, and T. Sawada, Pulmonary hypertension in type I glycogen storage disease, Pediatric Cardiology, vol.37, issue.1, pp.54-60, 1990.
DOI : 10.1007/BF02239550

D. Elstein, M. Klutstein, A. Lahad, A. Abrahamov, I. Hadas-halpern et al., Echocardiographic assessment of pulmonary hypertension in Gaucher's disease, The Lancet, vol.351, issue.9115, pp.1544-1550, 1998.
DOI : 10.1016/S0140-6736(98)10194-0

J. Chu, P. Kao, J. Faul, and R. Doyle, High Prevalence of Autoimmune Thyroid Disease in Pulmonary Arterial Hypertension, Chest, vol.122, issue.5, pp.1668-73, 2002.
DOI : 10.1378/chest.122.5.1668

M. Anderson, J. Kriett, D. Kapelanski, R. Tarazi, and S. Jamieson, Primary pulmonary artery sarcoma: A report of six cases, The Annals of Thoracic Surgery, vol.59, issue.6, pp.1487-90, 1995.
DOI : 10.1016/0003-4975(95)00149-F

A. Davis, R. Pierson, and J. Loyd, Mediastinal fibrosis1, Seminars in Respiratory Infections, vol.16, issue.2, pp.119-149, 2001.
DOI : 10.1053/srin.2001.24242

M. Yigla, F. Nakhoul, A. Sabag, N. Tov, B. Gorevich et al., Pulmonary Hypertension in Patients With End-Stage Renal Disease, Chest, vol.123, issue.5, pp.1577-82, 2003.
DOI : 10.1378/chest.123.5.1577

S. Gaine and L. Rubin, Primary pulmonary hypertension, The Lancet, vol.352, issue.9129, pp.719-725, 1998.
DOI : 10.1016/S0140-6736(98)02111-4

S. Rich, D. Dantzker, S. Ayres, E. Bergofsky, B. Brundage et al., Primary Pulmonary Hypertension, Annals of Internal Medicine, vol.107, issue.2, pp.216-223, 1987.
DOI : 10.7326/0003-4819-107-2-216

B. Mcquillan, M. Picard, M. Leavitt, and A. Weyman, Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation, pp.2797-2802

A. Maceira, S. Prasad, M. Khan, and D. Pennell, Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance, European Heart Journal, vol.27, issue.23, pp.2879-88, 2007.
DOI : 10.1093/eurheartj/ehl336

M. Hoeper, S. Lee, R. Voswinckel, M. Palazzini, X. Jaïs et al., Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers, Journal of the American College of Cardiology, vol.48, issue.12, pp.2546-52, 2006.
DOI : 10.1016/j.jacc.2006.07.061

O. Sitbon, M. Humbert, X. Jaïs, V. Ioos, A. Hamid et al., Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension, Circulation, vol.111, issue.23, pp.3105-3111, 2005.
DOI : 10.1161/CIRCULATIONAHA.104.488486

F. Brenot, Primary Pulmonary Hypertension, Chest, vol.105, issue.2, pp.33-36, 1994.
DOI : 10.1378/chest.105.2_Supplement.33S

G. Alonzo, R. Barst, S. Ayres, E. Bergofsky, B. Brundage et al., Survival in Patients with Primary Pulmonary Hypertension, Annals of Internal Medicine, vol.115, issue.5, pp.343-352, 1991.
DOI : 10.7326/0003-4819-115-5-343

B. Kurtz and F. Bauer, Evaluation de la fonction cardiaque droite. Revues générales échocardiographique 51

R. Raymond, A. Hinderliter, P. Willis, D. Ralph, E. Caldwell et al., Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension, Journal of the American College of Cardiology, vol.39, issue.7, pp.1214-1223, 2002.
DOI : 10.1016/S0735-1097(02)01744-8

G. Alonzo, R. Barst, S. Ayres, E. Bergofsky, B. Brundage et al., Survival in Patients with Primary Pulmonary Hypertension, Annals of Internal Medicine, vol.115, issue.5, pp.343-349, 1991.
DOI : 10.7326/0003-4819-115-5-343

G. Paciocco, F. Martinez, E. Bossone, E. Piel-sticker, B. Gillespie et al., Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension, European Respiratory Journal, vol.17, issue.4, pp.647-52, 2001.
DOI : 10.1183/09031936.01.17406470

S. Miyamoto, N. Nagaya, T. Satoh, S. Kyotani, F. Sakamaki et al., Clinical Correlates and Prognostic Significance of Six-minute Walk Test in Patients with Primary Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.161, issue.2, pp.487-492, 2000.
DOI : 10.1164/ajrccm.161.2.9906015

N. Nagaya, M. Uematsu, T. Satoh, S. Kyotani, F. Sakamaki et al., Serum Uric Acid Levels Correlate with the Severity and the Mortality of Primary Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.160, issue.2, pp.487-92, 1999.
DOI : 10.1164/ajrccm.160.2.9812078

N. Nagaya, T. Nishikimi, M. Uematsu, T. Satoh, S. Kyotani et al., Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension, Circulation, vol.102, issue.8, pp.865-70, 2000.
DOI : 10.1161/01.CIR.102.8.865

A. Torbicki, M. Kurzyna, P. Kuca, A. Fijalkowska, J. Sikora et al., Detectable Serum Cardiac Troponin T as a Marker of Poor Prognosis Among Patients With Chronic Precapillary Pulmonary Hypertension, Circulation, vol.108, issue.7, pp.844-852, 2003.
DOI : 10.1161/01.CIR.0000084544.54513.E2

P. Forfia, S. Mathai, M. Fisher, T. Housten-harris, A. Hemnes et al., Hyponatremia Predicts Right Heart Failure and Poor Survival in Pulmonary Arterial Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.177, issue.12, pp.1364-1373, 2008.
DOI : 10.1164/rccm.200712-1876OC

C. Rubens, R. Ewert, M. Halank, R. Wensel, H. Orzechowski et al., Big Endothelin-1 and Endothelin-1 Plasma Levels Are Correlated With the Severity of Primary Pulmonary Hypertension, Chest, vol.120, issue.5, pp.1562-1571, 2001.
DOI : 10.1378/chest.120.5.1562

R. Naeije and J. Vachiery, MEDICAL THERAPY OF PULMONARY HYPERTENSION, Clinics in Chest Medicine, vol.22, issue.3, pp.517-544, 2001.
DOI : 10.1016/S0272-5231(05)70288-4

E. Bedard, K. Dimopoulos, and M. Gatzoulis, Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?, European Heart Journal, vol.30, issue.3, pp.256-65, 2009.
DOI : 10.1093/eurheartj/ehn597

O. Sanchez, E. Marié, U. Lerolle, D. Wermet, D. Israël-biet et al., Hypertension art??rielle pulmonaire f??minine, Revue des Maladies Respiratoires, vol.25, issue.4, pp.451-60, 2008.
DOI : 10.1016/S0761-8425(08)71585-7

R. Spence, A. Mandagere, G. Walker, C. Dufton, and R. Boinpally, Effect of Steady-State Ambrisentan on the Pharmacokinetics of a Single Dose of the Oral Contraceptive Norethindrone (Norethisterone) 1???mg/Ethinylestradiol 35?????g in Healthy Subjects, Clinical Drug Investigation, vol.75, issue.5, pp.313-337, 2010.
DOI : 10.2165/11534940-000000000-00000

S. Thorne, C. Nelson-piercy, A. Macgregor, S. Gibbs, J. Crowhurst et al., Pregnancy and contraception in heart disease and pulmonary arterial hypertension, Journal of Family Planning and Reproductive Health Care, vol.32, issue.2, pp.75-80, 2006.
DOI : 10.1783/147118906776276486

L. Price, D. Montani, X. Jaïs, J. Dick, G. Simmonneau et al., Non-cardiothoracic non obstetric surgery in mild-moderate pulmonary hypertension : Perioperative management of 28 consecutive individual cases, Eur Respir J, vol.35, pp.1-9, 2010.

E. Weitzenblum, A. Sautegeau, M. Ehrart, M. Mammoser, and A. Pelletier, Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease, Am Rev Respir Dis, pp.131493-498, 1985.

V. Fuster, P. Steele, W. Edwards, B. Gersh, M. Mcgoon et al., Primary pulmonary hypertension: natural history and the importance of thrombosis, Circulation, vol.70, issue.4, pp.70580-70587, 1984.
DOI : 10.1161/01.CIR.70.4.580

S. Rich, M. Seidlitz, E. Dodin, D. Osimani, D. Judd et al., The Short-term Effects of Digoxin in Patients With Right Ventricular Dysfunction From Pulmonary Hypertension, Chest, vol.114, issue.3, pp.787-792, 1998.
DOI : 10.1378/chest.114.3.787

S. Rich, E. Kaufmann, and P. Levy, The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension, New England Journal of Medicine, vol.327, issue.2, pp.76-81, 1992.
DOI : 10.1056/NEJM199207093270203

X. Jaïs and D. Bonnet, Traitement de l???hypertension art??rielle pulmonaire, La Presse M??dicale, vol.39, pp.1-22, 2010.
DOI : 10.1016/S0755-4982(10)70004-X

R. Channick, G. Simmonneau, O. Sitbon, I. Robbins, A. Frost et al., Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study, The Lancet, vol.358, issue.9288, pp.1119-1142, 2001.
DOI : 10.1016/S0140-6736(01)06250-X

N. Galié, M. Beghetti, M. Gatzoulis, J. Granton, R. Berger et al., Bosentan Therapy in Patients With Eisenmenger Syndrome: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study, Circulation, vol.114, issue.1, pp.48-54, 2006.
DOI : 10.1161/CIRCULATIONAHA.106.630715

N. Galié, L. Rubin, M. Hoeper, P. Jansa, H. Hiti et al., Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial, The Lancet, vol.371, issue.9630, pp.2093-100, 2008.
DOI : 10.1016/S0140-6736(08)60919-8

V. Mclaughlin, O. Sitbon, D. Badesch, R. Barst, C. Black et al., Survival with first-line bosentan in patients with primary pulmonary hypertension, European Respiratory Journal, vol.25, issue.2, pp.244-253, 2005.
DOI : 10.1183/09031936.05.00054804

M. Humbert, E. Segal, D. Kiely, J. Carlsen, B. Schwierin et al., Results of European post-marketing surveillance of bosentan in pulmonary hypertension, European Respiratory Journal, vol.30, issue.2, pp.338-382, 2007.
DOI : 10.1183/09031936.00138706

N. Galié, D. Badesch, R. Oudiz, G. Simonneau, M. Mcgoon et al., Ambrisentan Therapy for Pulmonary Arterial Hypertension, Journal of the American College of Cardiology, vol.46, issue.3, pp.529-564, 2005.
DOI : 10.1016/j.jacc.2005.04.050

N. Galié, H. Olschewski, R. Oudiz, F. Torres, A. Frost et al., Ambrisentan for the Treatment of Pulmonary Arterial Hypertension: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2, Circulation, vol.117, issue.23, pp.3010-3019, 2008.
DOI : 10.1161/CIRCULATIONAHA.107.742510

M. Mcgoon, A. Frost, R. Oudiz, B. Badesch, N. Galié et al., Ambrisentan Therapy in Patients With Pulmonary Arterial Hypertension Who Discontinued Bosentan or Sitaxsentan Due to Liver Function Test Abnormalities, Chest, vol.135, issue.1, pp.122-129, 2009.
DOI : 10.1378/chest.08-1028

N. Galié, H. Ghofrani, A. Torbicki, R. Barst, L. Rubin et al., Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.353, issue.20, pp.2148-57, 2005.
DOI : 10.1056/NEJMoa050010

N. Galié, B. Brundage, H. Ghofrani, R. Oudiz, G. Simonneau et al., Tadalafil Therapy for Pulmonary Arterial Hypertension, Circulation, vol.119, issue.22, pp.2894-903, 2009.
DOI : 10.1161/CIRCULATIONAHA.108.839274

H. Ghofrani, M. Hoeper, M. Halank, F. Meyer, G. Staehle et al., Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study, European Respiratory Journal, vol.36, issue.4, pp.792-801, 2010.
DOI : 10.1183/09031936.00182909

R. Barst, L. Rubin, W. Long, M. Mcgoon, S. Rich et al., A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension, New England Journal of Medicine, vol.334, issue.5, pp.296-302, 1996.
DOI : 10.1056/NEJM199602013340504

O. Sitbon, M. Humbert, H. Nunes, F. Parent, G. Garcia et al., Long-term intravenous epoprostenol infusion in primary pulmonary hypertension, Journal of the American College of Cardiology, vol.40, issue.4, pp.780-788, 2002.
DOI : 10.1016/S0735-1097(02)02012-0

S. Rich and V. Mclaughlin, The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension, Journal of the American College of Cardiology, vol.34, issue.4, pp.34-1184, 1999.
DOI : 10.1016/S0735-1097(99)00320-4

G. Simonneau, R. Barst, N. Galié, R. Naeije, S. Rich et al., Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.165, issue.6, pp.800-804, 2002.
DOI : 10.1164/ajrccm.165.6.2106079

H. Olschewski, G. Simonneau, N. Galié, T. Higenbottam, R. Naije et al., Inhaled Iloprost for Severe Pulmonary Hypertension, New England Journal of Medicine, vol.347, issue.5, pp.322-331, 2002.
DOI : 10.1056/NEJMoa020204

H. Ghofrani, F. Rose, R. Schermuly, H. Olschewski, R. Wiedermann et al., Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension, Journal of the American College of Cardiology, vol.42, issue.1, pp.158-164, 2006.
DOI : 10.1016/S0735-1097(03)00555-2

M. Horper, C. Faulenbach, H. Golpon, J. Winkler, T. Welte et al., Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension, Eur Respir J, vol.24, pp.1007-1010, 2004.

S. Mathai, R. Girgis, M. Fisher, H. Champion, T. Housten-harris et al., Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension, European Respiratory Journal, vol.29, issue.3, pp.469-475, 2007.
DOI : 10.1183/09031936.00081706

M. Kurzyna, M. Dabrowski, D. Bielecki, A. Fijalkowska, P. Pruszczyk et al., Atrial Septostomy in Treatment of End-Stage Right Heart Failure in Patients With Pulmonary Hypertension, Chest, vol.131, issue.4, pp.977-83, 2007.
DOI : 10.1378/chest.06-1227

J. Sandoval, A. Rothman, and T. Pulido, ATRIAL SEPTOSTOMY FOR PULMONARY HYPERTENSION, Clinics in Chest Medicine, vol.22, issue.3, pp.547-60, 2001.
DOI : 10.1016/S0272-5231(05)70291-4

J. Sandoval, J. Gaspar, T. Pulido, E. Bautista, M. Martinez-guerra et al., Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension, Journal of the American College of Cardiology, vol.32, issue.2, pp.297-304, 1998.
DOI : 10.1016/S0735-1097(98)00238-1

E. Trulock, L. Edwards, T. D. Boucek, M. Keck, B. Hertz et al., Registry of the International Society for Heart and Lung Transplantation: Twenty-third Official Adult Lung and Heart???Lung Transplantation Report???2006, The Journal of Heart and Lung Transplantation, vol.25, issue.8, pp.880-92, 2006.
DOI : 10.1016/j.healun.2006.06.001

G. Alonso, R. Barst, S. Ayres, E. Bergofsky, B. Brundage et al., Survival in Patients with Primary Pulmonary Hypertension, Annals of Internal Medicine, vol.115, issue.5, pp.343-352, 1991.
DOI : 10.7326/0003-4819-115-5-343

F. Brenot, Primary Pulmonary Hypertension, Chest, vol.105, issue.2, pp.33-365, 1994.
DOI : 10.1378/chest.105.2_Supplement.33S

E. Hachulla, V. Gressin, L. Guillevin, P. Carpentier, E. Diot et al., Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study, Arthritis & Rheumatism, vol.351, issue.12, pp.3792-800, 2005.
DOI : 10.1002/art.21433

M. Gladwin, V. Sachdev, M. Jison, Y. Shizukuda, J. Plehn et al., Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease, New England Journal of Medicine, vol.350, issue.9, pp.886-95, 2004.
DOI : 10.1056/NEJMoa035477

O. Sitbon, C. Lascoux-combe, J. Delfraissy, P. Yeni, F. Raffi et al., Prevalence of HIV-related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era, American Journal of Respiratory and Critical Care Medicine, vol.177, issue.1, pp.108-121, 2008.
DOI : 10.1164/rccm.200704-541OC

G. Alonzo, R. Barst, and S. Ayres, Survival in patients with primary pulmonary hypertension. Results from a national prospective study, Ann Intern Med, pp.343-352, 1991.

V. Cottin, Hypertension art??rielle pulmonaire associ??e aux connectivites, Revue des Maladies Respiratoires, vol.23, issue.4, pp.61-72, 2006.
DOI : 10.1016/S0761-8425(06)71798-3

O. Sanchez, O. Sitbon, and G. Garcia, Pulmonary artery hypertension associated with connective tissue diseases, Press Med, vol.32, pp.789-99, 2003.

M. Humbert, O. Sitbon, and A. Chaouat, Pulmonary Arterial Hypertension in France, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.9, pp.1023-1053, 2006.
DOI : 10.1164/rccm.200510-1668OC

H. Nunes, M. Humbert, and O. Sitbon, Prognostic Factors for Survival in Human Immunodeficiency Virus???associated Pulmonary Arterial Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.167, issue.10, pp.1433-1442, 2003.
DOI : 10.1164/rccm.200204-330OC

M. Humbert, O. Sitbon, and A. Chaouat, Pulmonary Arterial Hypertension in France, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.9, pp.1023-1053, 2006.
DOI : 10.1164/rccm.200510-1668OC

M. Humbert, O. Sitbon, and A. Chaouat, Pulmonary Arterial Hypertension in France, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.9, pp.1023-1053, 2006.
DOI : 10.1164/rccm.200510-1668OC

G. Alonzo, R. Barst, and S. Ayres, Survival in patients with primary pulmonary hypertension. Results from a national prospective study, Ann Intern Med, pp.343-352, 1991.

R. Oudiz, A. Widlitz, X. Beckmann, D. Camanga, A. J. Brundage et al., Micrococcus-Associated Central Venous Catheter Infection in Patients With Pulmonary Arterial Hypertension, Chest, vol.126, issue.1, pp.90-94, 2004.
DOI : 10.1378/chest.126.1.90

C. Opitz, R. Wensel, J. Winkler, M. Halank, L. Bruch et al., Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension, European Heart Journal, vol.26, issue.18, pp.1895-902, 2005.
DOI : 10.1093/eurheartj/ehi283

D. Badesch, V. Tapson, M. Goon, M. Brundage, B. Rubin et al., Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease, Annals of Internal Medicine, vol.132, issue.6, pp.425-459, 2000.
DOI : 10.7326/0003-4819-132-6-200003210-00002